JESDUVROQ

Drug GlaxoSmithKline, LLC.
Total Payments
$405,207
Transactions
2,771
Doctors
1,568
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $127,849 893 704
2023 $277,358 1,878 1,226

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $235,625 83 58.1%
Food and Beverage $74,521 2,485 18.4%
Travel and Lodging $38,058 84 9.4%
Unspecified $33,434 5 8.3%
Consulting Fee $19,381 7 4.8%
Education $4,188 107 1.0%

Payments by Type

General
$371,773
2,766 transactions
Research
$33,434
5 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
221001 GlaxoSmithKline, LLC. $33,434 0

Top Doctors Receiving Payments for JESDUVROQ

Doctor Specialty Location Total Records
, MD Nephrology Indianapolis, IN $59,108 47
, MD Nephrology Los Angeles, CA $38,183 34
Erica Baugh Irvine, CA $33,807 15
, MD, PHD Internal Medicine Meridian, ID $29,033 27
, M.D Nephrology Bronx, NY $24,657 15
, M.D Nephrology Port Royal, SC $22,195 20
, M.D Nephrology Los Angeles, CA $17,375 11
, MD Nephrology Pompano Beach, FL $15,615 14
, MD Nephrology Chicopee, MA $14,269 11
, M.D Internal Medicine Houston, TX $13,507 8
, M.D Nephrology Sacramento, CA $12,227 8
, M.D Nephrology Orangeburg, SC $7,996 7
, MD Internal Medicine Scottsdale, AZ $6,850 5
, MD Nephrology San Antonio, TX $6,636 10
, M.D Specialist Staten Island, NY $6,143 3
, M.D Nephrology Arab, AL $6,064 10
, M.D Internal Medicine Dallas, TX $5,791 8
, M.D Internal Medicine Mineola, NY $5,320 4
, M.D., SC.D Internal Medicine Houston, TX $3,656 3
, NP-C Family South Miami, FL $2,680 4
, MD Nephrology Port Charlotte, FL $975.00 1
, M.D Nephrology Evergreen Park, IL $650.00 1
, MD Nephrology Lufkin, TX $425.63 7
, D.O Internal Medicine Atlanta, GA $285.11 6
, M.D Student in an Organized Health Care Education/Training Program Lompoc, CA $258.81 4

About JESDUVROQ

JESDUVROQ is a drug associated with $405,207 in payments to 1,568 healthcare providers, recorded across 2,771 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..

Payment data is available from 2023 to 2024. In 2024, $127,849 was paid across 893 transactions to 704 doctors.

The most common payment nature for JESDUVROQ is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($235,625, 58.1% of total).

JESDUVROQ is associated with 1 research study, including "221001" ($33,434).